32,365 Shares in Amrize Ltd $AMRZ Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. purchased a new stake in Amrize Ltd (NYSE:AMRZ) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 32,365 shares of the company’s stock, valued at approximately $1,220,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AMRZ. Amundi lifted its holdings in shares of Amrize by 30.9% during the first quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. DJE Kapital AG grew its stake in shares of Amrize by 45.9% in the first quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock worth $60,194,000 after purchasing an additional 350,149 shares during the last quarter. Great Lakes Advisors LLC bought a new stake in shares of Amrize in the second quarter worth $16,975,000. Ancora Advisors LLC bought a new stake in shares of Amrize in the second quarter worth $15,112,000. Finally, Assetmark Inc. increased its holdings in Amrize by 18,567.2% in the first quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock valued at $14,055,000 after purchasing an additional 249,543 shares during the period.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 target price on shares of Amrize in a research report on Monday, September 21st. Deutsche Bank Aktiengesellschaft reduced their price target on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Bank of America cut Amrize from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $50.00 to $40.00 in a research note on Wednesday, September 2nd. Longbow Research assumed coverage on Amrize in a research note on Monday, October 12th. They issued a “buy” rating for the company. Finally, Oppenheimer lowered their price objective on Amrize from $55.00 to $52.00 and set an “outperform” rating for the company in a research report on Monday, November 2nd. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $49.06.

Insider Transactions at Amrize

In other Amrize news, Director Jacques Sanche bought 4,150 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average price of $45.02 per share, with a total value of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Mario Gross bought 3,568 shares of the stock in a transaction on Tuesday, August 11th. The stock was acquired at an average price of $46.60 per share, with a total value of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares of the company’s stock, valued at $1,793,401. This represents a 10.22% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders purchased 48,983 shares of company stock worth $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Amrize Trading Down 1.8%

NYSE:AMRZ opened at $41.90 on Friday. Amrize Ltd has a 52 week low of $35.78 and a 52 week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.67 and a current ratio of 1.07. The firm’s fifty day moving average is $39.53 and its 200-day moving average is $50.30. The firm has a market cap of $23.17 billion, a P/E ratio of 18.96, a P/E/G ratio of 1.64 and a beta of 0.04.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The business had revenue of $3.77 billion during the quarter. During the same period in the prior year, the business earned $0.98 EPS. Amrize’s quarterly revenue was up 2.6% on a year-over-year basis. Equities analysts expect that Amrize Ltd will post 2.30 earnings per share for the current year.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be given a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is 4.98%.

Amrize Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.